scholarly journals Early Ultrasound Fetal Parameters as a Predictor for Pregnancy Outcome: A Prospective Observational Cohort Study

2019 ◽  
Vol I (1) ◽  
pp. 07-12
Author(s):  
: Ahmed Ali M. Nasr

Background Ongoing technological advancements have allowed the resolution of ultrasound imaging in the first trimester to evolve to a level at which early fetal development can be assessed and monitored in detail. Objective To find a relation between first-trimester ultrasound fetal measurements and adverse pregnancy outcomes. Subjects and Methods A prospective observational cohort study conducted on 500 pregnant women at 1st trimester attending ANC clinic of obs& gyne. department of Al-Azhar university hospital (Assiut -Egypt). Ultrasound measurements of early fetal parameter GSD, CRL and YSD at 5-12 weeks of gestation were done. Results of measurements were classified into three classes, class A<10th centile, class B 10th-90th centile and Class C>90th centile. Patients were followed up throughout pregnancy to determine normal and abnormal outcomes in each class. Comparison between different classes was made to show association with abnormal pregnancy outcomes. Results Early fetal ultrasonographic parameters class A & C were significantly associated with 1st, 2nd-trimester abortions, IUFD, APH and PROM (p<0.001) with no significant association between these parameters and other pregnancy outcomes (p>0.05). Conclusion Our study emphasizes the role of early ultrasound in predicting abnormal pregnancy outcomes it could be useful to obstetricians to anticipate adverse outcomes and being warned to manage prenatal care and delivery more appropriately. Recommendation Early fetal ultrasound should be used as a tool to predict pregnancy outcome so as to manage prenatal care and delivery more efficiently

2017 ◽  
Vol 26 (10) ◽  
pp. 1197-1204 ◽  
Author(s):  
Katarina Dathe ◽  
Stephanie Padberg ◽  
Stefanie Hultzsch ◽  
Katja Meixner ◽  
Tatjana Tissen-Diabaté ◽  
...  

2017 ◽  
Vol 72 ◽  
pp. 207
Author(s):  
Katarina Dathe ◽  
Stephanie Padberg ◽  
Stefanie Hultzsch ◽  
Katja Meixner ◽  
Tatjana Tissen-Diabaté ◽  
...  

2017 ◽  
Vol 72 ◽  
pp. 204
Author(s):  
Maria Hoeltzenbein ◽  
Evelin Beck ◽  
Anne-Katrin Fietz ◽  
Juliane Wernicke ◽  
Sandra Zinke ◽  
...  

Cephalalgia ◽  
2017 ◽  
Vol 38 (6) ◽  
pp. 1081-1092 ◽  
Author(s):  
Kevin Spielmann ◽  
Angela Kayser ◽  
Evelin Beck ◽  
Reinhard Meister ◽  
Christof Schaefer

Objective The objective of our study is to assess the impact of triptan exposure on pregnancy outcome. Methods We performed a prospective observational cohort study with 432 pregnant women exposed to triptans and enrolled by the German Embryotox system. Pregnancy outcomes were compared with a migraine and a non-migraine comparison cohort. Primary objectives were major birth defects and spontaneous abortion; secondary endpoints were preterm delivery, birth weight, pregnancy complications and the rate of electively terminated pregnancies. Results Compared to a non-migraine cohort the rates of major birth defects (ORadj 0.84; 95% CI 0.4–1.9), spontaneous abortions (ORadj 1.20; 95% CI 0.9–1.7), preterm delivery (ORadj 1.01; 95% CI 0.7–1.5), and preeclampsia (ORadj 1.33; 95% CI 0.7–2.5) were not increased in triptan-exposed pregnancies. Conclusions Our findings support the evidence that triptans are not major teratogens. When compellingly needed during pregnancy, sumatriptan as the best studied triptan appears an acceptable treatment option. A detailed fetal ultrasound should be offered in cases of first trimester exposure to less well-studied triptans. Trial registration number in German Clinical Trials Register: DRKS00007660


2017 ◽  
Vol 9 ◽  
pp. 21
Author(s):  
Maria Hoeltzenbein ◽  
Anne-Katrin Fietz ◽  
Evelin Beck ◽  
Juliane Wernicke ◽  
Angela Kayser ◽  
...  

Infection ◽  
2019 ◽  
Vol 48 (1) ◽  
pp. 57-64 ◽  
Author(s):  
Wayan Philipps ◽  
Anne-Katrin Fietz ◽  
Katja Meixner ◽  
Tobias Bluhmki ◽  
Reinhard Meister ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document